Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ring-Larsen

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1977
Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver functionH Ring-Larsen
Ugeskrift for Laeger|August 7, 1995
[Paracetamol poisoning]H Ring-Larsen
Acta Medica Scandinavica|May 1, 1974
Bumetanide in the treatment of hepatic ascites. A short and long-term studyH Ring-Larsen
Acta Ophthalmologica|February 1, 1977
Ocular function in cirrhosis of the liverE Krogh, H Ring-Larsen
Ugeskrift for Laeger|July 30, 1979
[Accidentally induced malaria]H Ring-Larsen, S Jepsen
Gut|July 1, 1981
Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosisH Ring-Larsen, U Palazzo
Seminars in Liver Disease|November 1, 1986
Pathogenesis of ascites formation and hepatorenal syndrome: humoral and hemodynamic factorsH Ring-Larsen, J H Henriksen
Ugeskrift for Laeger|July 13, 1981
[Brucellosis as a tourist disease. Report of 2 cases with liver granuloma]J K Heiberg, H Ring-Larsen
Hepatology (Baltimore, Md.)|September 1, 1993
Renal effects of drugs used in the treatment of portal hypertensionJ H Henriksen, H Ring-Larsen
Current Pharmaceutical Design|December 16, 2006
Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosisL E Schmidt, H Ring-Larsen
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Scandinavian Journal of Clinical and Laboratory Investigation|November 1, 1977
Renal blood flow in cirrhosis: relation to systemic and portal haemodynamics and liver functionH Ring-Larsen
Ugeskrift for Laeger|August 7, 1995
[Paracetamol poisoning]H Ring-Larsen
Acta Medica Scandinavica|May 1, 1974
Bumetanide in the treatment of hepatic ascites. A short and long-term studyH Ring-Larsen
Acta Ophthalmologica|February 1, 1977
Ocular function in cirrhosis of the liverE Krogh, H Ring-Larsen
Ugeskrift for Laeger|July 30, 1979
[Accidentally induced malaria]H Ring-Larsen, S Jepsen
Gut|July 1, 1981
Renal failure in fulminant hepatic failure and terminal cirrhosis: a comparison between incidence, types, and prognosisH Ring-Larsen, U Palazzo
Seminars in Liver Disease|November 1, 1986
Pathogenesis of ascites formation and hepatorenal syndrome: humoral and hemodynamic factorsH Ring-Larsen, J H Henriksen
Ugeskrift for Laeger|July 13, 1981
[Brucellosis as a tourist disease. Report of 2 cases with liver granuloma]J K Heiberg, H Ring-Larsen
Hepatology (Baltimore, Md.)|September 1, 1993
Renal effects of drugs used in the treatment of portal hypertensionJ H Henriksen, H Ring-Larsen
Current Pharmaceutical Design|December 16, 2006
Vasoconstrictor therapy for hepatorenal syndrome in liver cirrhosisL E Schmidt, H Ring-Larsen
Pageof 9